Diagnostic and prognostic value of the Chinese Visceral Adipose Index in patients with coronary heart disease and metabolic syndrome undergoing percutaneous coronary intervention: a single-centre retrospective study
The CVAI showed good diagnostic performance in identifying MetS, outperforming several conventional indices in estimating visceral adiposity. It also demonstrated prognostic value in predicting MACEs within 12 months among patients with MetS and CHD undergoing PCI. These findings suggest that CVAI shows promise as a potential clinical tool for cardiometabolic risk assessment and secondary prevention in this patient population, though further validation in larger, prospective studies is warranted.
Authors
- Ying Chen (ORCID: https://orcid.org/0000-0002-5812-6277)
- Xu Chen
- Fengqi Liu (ORCID: https://orcid.org/0000-0002-7504-2243)
- Jingjing Shi (ORCID: https://orcid.org/0000-0002-4532-4573)
- Qian Cao (ORCID: https://orcid.org/0009-0006-8105-5047)
- Wenjing Xu (ORCID: https://orcid.org/0000-0003-3399-0867)
- Jinyou Song (ORCID: https://orcid.org/0000-0001-7540-5182)
Institutions
- Jiangnan University (CN)
- Wuxi Fourth People's Hospital (CN)
- Wuhan Sixth Hospital (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-104778
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangnan University